Bafna Pharmaceuticals’ facility has received renewal approval as per the Guidelines of European Good Manufacturing Practices (EUGMP) from Medicines and Healthcare products Regulatory Agency (MHRA).
Bafna Pharmaceuticals is engaged in the production of tablets, capsule and oral syrup.